Citicoline

An intermediate in the synthesis of phosphatidylcholine

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
100mg

￥425.00

340.00

- +
500mg

￥762.00

610.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajce55648
CAS: 987-78-0
别名: 胞磷胆碱; Cytidine diphosphate-choline; CDP-Choline; Cytidine 5'-diphosphocholine
分子式: C14H26N4O11P2
分子量: 488.32
纯度: >98%
溶解度: Water : 300 mg/mL (586.73 mM); DMSO: < 1 mg/mL (insoluble or slightly soluble)
储存: Store at -20°C
库存: 现货

Background

Citicoline is an endogenous intermediate in the synthesis of phosphatidylcholine, the major phospholipid in eukaryotic cells.¹ It also serves as a choline donor in the biosynthesis of the neurotransmitter acetylcholine. Citicholine demonstrates protective effects in cerebral ischemia, traumatic brain injury, and memory disorders.² Exogenous administration of citicholine to rodents (500 mg/kg i.p. immediately after ischemia and at 3-h reperfusion) has been shown to stimulate the synthesis of phosphatidylcholine, sphingomyelin, and cardiolipin and to attenuate the release of arachidonic acid and the accumulation of ceramide.³

1.McMaster, C.R., and Bell, R.M.Phosphatidylcholine biosynthesis via the CDP-choline pathway in Saccharomyces cerevisiaeJ. Biol. Chem.269(20)14776-14783(1994) 2.Dávalos, A., and Secades, J.Citicoline preclinical and clinical update 2009-2010Stroke42(1)36-39(2011) 3.Rao, M., Hatcher, J.F., and Dempsey, R.J.Lipid alterations in transient forebrain ischemia: Possible new mechanisms of CDP-choline neuroprotectionJ. Neurochem.75(6)2528-2535(2000)

Protocol

Cell experiment:

The assay used to assess cell viability in retinal cells was the MTT reduction assay. To evaluate the effect of Citicoline and Homotaurine on cell survival, the cells are subdivided into three groups and treated for 24 hours with 1?μM, 10?μM, and 100?μM of Citicoline and with 1?μM, 10?μM and 100?μM of Homotaurine. To evaluate the neuroprotective effects of Citicoline and Homotaurine, cells are treated with Citicoline 100?μM, Homotaurine 100?μM, or Citicoline+Homotaurine 100?μM, 24 hours before glutamate treatment and 30?min before high glucose (HG) treatment. MTT is added to wells at a final concentration of 0.5mg/mL for 1 hour at 37°C. After this time, the medium is removed and reduced MTT (blue formazan product) is solubilized by adding 100?μL DMSO to each well. After agitation of plates for 15?min, the optical density of the solubilized formazan product in each well is measured using an automatic microplate reader with a 570?nm test wavelength and a 690?nm reference wavelength[1].

Animal experiment:

Mice[1]Experiments are performed on male C57Bl/6 mice (n=69) weighing 23-27 g. The study is performed in two series. In series I, the dose-dependent effect of Citicoline on the seizure threshold in mice is evaluated. The measurements are performed 1 h after Citicoline administration. Citicoline in doses of 500 and 1000 mg/kg (0.04 mL per 20 g body weight) is injected intraperitoneally. The control animals receive an equivalent volume of physiological saline under similar conditions. In series II, the duration of Citicoline effect is estimated in 3 and 6 h after single intraperitoneal injection of Citicoline.

参考文献:

[1]. Davinelli S, et al. Cytoprotective Effects of Citicoline and Homotaurine against Glutamate and High Glucose Neurotoxicity in Primary Cultured Retinal Cells. Oxid Med Cell Longev. 2017;2017:2825703.
[2]. Karpova MN, et al. Increase of the seizure threshold in C57BL/6 mice after citicoline administration. Bull Exp Biol Med. 2015 Jan;158(3):315-7.